Inv(3)(q21q26)과 BCR/ABL1 잠재전이가 함께 관찰된 모세포위기 만성골수성백혈병 1예
A Case of Concomitant Inv(3)(q21q26) and Cryptic BCR/ABL1 Rearrangement in the Blast Crisis of Chronic Myeloid Leukemia
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Structural abnormalities of the long arm of chromosome 3 (3q) have been associated with elevated platelet count and hyperplasia of megakaryocytes with dysplasia in various hematological malignancies. Some cases of chronic myeloid leukemia (CML) may acquire inv(3) (q21q26) or t(3;3)(q21;q26), and such a finding usually indicates accelerated or blast phase of their disease. We report a case of concomitant inv(3) (q21q26) and cryptic BCR/ABL1 rearrangement in the blast crisis of CML. The patient was 17-year-old male and showed marked leukocytosis and thrombocytosis at admission. Leukocyte differentials showed eosinophilia, basophilia and increased blasts. The bone marrow was hypercellular with granulocytic hyperplasia, and dysmorphic megakaryocytes were frequently observed. Conventional cytogenetic analysis revealed only an inv(3)(q21q26)and no Philadelphia chromosome was observed. FISH and RT-PCR analyses confirmed cryptic BCR/ABL1 rearrangement. The patient responded poorly with imatinib and induction chemotherapy, and expired during the course of 2nd chemotherapy with increased dose of imatinib.
Abstract
Structural abnormalities of the long arm of chromosome 3 (3q) have been associated with elevated platelet count and hyperplasia of megakaryocytes with dysplasia in various hematological malignancies. Some cases of chronic myeloid leukemia (CML) may acquire inv(3) (q21q26) or t(3;3)(q21;q26), and such a finding usually indicates accelerated or blast phase of their disease. We report a case of concomitant inv(3) (q21q26) and cryptic BCR/ABL1 rearrangement in the blast crisis of CML. The patient was 17-year-old male and showed marked leukocytosis and thrombocytosis at admission. Leukocyte differentials showed eosinophilia, basophilia and increased blasts. The bone marrow was hypercellular with granulocytic hyperplasia, and dysmorphic megakaryocytes were frequently observed. Conventional cytogenetic analysis revealed only an inv(3)(q21q26)and no Philadelphia chromosome was observed. FISH and RT-PCR analyses confirmed cryptic BCR/ABL1 rearrangement. The patient responded poorly with imatinib and induction chemotherapy, and expired during the course of 2nd chemotherapy with increased dose of imatinib.
참고문헌 (19)
- Rowley JD, "Chromosomal banding patterns in acute nonlymphocytic leukemia", Blood, 47, pp.705~721 (1976)
- Testoni N, "3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: biological and clinical features", Haematologica, 84, pp.690~694 (1999)
- Quintás-Cardama A, "Association of 3q21q26 syndrome and late-appearing Philadelphia chromosome in acute myeloid leukemia", Leukemia, 22, pp.877~878 (2008)
- Shi G, "Chromosomal abnormality inv(3)(q21q26) associated with multilineage hematopoietic progenitor cells in hematopoietic malignancies", Cancer Genet Cytogenet, 96, pp.58~63 (1997)
- Wieser R, "Rearrangements of chromosome band 3q21 in myeloid leukemia", Leuk Lymphoma, 43, pp.59~65 (2002)
- Chang VT, "Acute myelogenous leukemia associated with extreme symptomatic thrombocytosis and chromosome 3q translocation: case report and review of literature", Am J Hematol, 72, pp.20~26 (2003)
- 정희정1, "3q21q26 증후군의 혈액학적, 임상적 소견: 불량한 예후 및 중추성 요붕증과의 연관성", Annals of Laboratory Medicine, 27(2), pp.133~138 (2007), 대한진단검사의학회
- Reiter E, "Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversioin inv (3)(q21q26) or homologous translocation t(3;3) (q21;q26)", Ann Hematol, 79, pp.374~377 (2000)
- Weisser M, "Advanced age and high initial WBC influence the outcome of inv(3)(q21q26)", t(3;3)(q21; q26) positive AML, 2007, pp.48, 2145~2151
- Lee YW, "3q chromosomal abnormalities associated with dysmegakaryopoiesis in acute leukemias", Korean J Clin Pathol, 21, pp.18~23 (2001)
- Garcia-Manero G, "Kantarjian HM. Chronic myelogenous leukemia: a review and update of therapeutic strategies", Cancer, 98, pp.437~457 (2003)
- Onida F, "Characteristics and outcome of patients with Philadelphia chromosome negative, bcr", abl negative chronic myelogenous leukemia, 2002, pp.95, 1673~1684
- 이선아, "A Case of t(3;3)(q21;q26.2) Associated with Severe Multilineage Dysplasia and Multi-drug Resistance in Blastic Crisis of Chronic Myelogenous Leukemia", Annals of Laboratory Medicine, 30(6), pp.595~599 (2010), 대한진단검사의학회
- Nucifora G, "EVI1 and hematopoietic disorders: history and perspectives", Gene, 368, pp.1~11 (2006)
- Lahortiga I, "Molecular heterogeneity in AML", MDS patients with 3q21q26 rearrangements, 2004, pp.40, 179~189
- Buonamici S, "The role of EVI1 in normal and leukemic cells", Blood Cells Mol Dis, 31, pp.206~212 (2003)
- Reddy KS, "A Philadelphia-negative chronic myeloid leukemia with a BCR", ABL fusion gene on chromosome 9, 1998, pp.107, 48~50
- Martiat P, "Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia", Blood, 78, pp.205~211 (1991), The Groupe Français de Cytogénétique Hématologique
- Swerdlow SH, "WHO classification of tumors of haematopoietic and lymphoid tissues", pp.116~117 (2008), International Agency for Research on Cancer